DICE Therapeutics, Inc.
DICE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1,229 | $313 | $857 | $857 |
| - Cash | $461 | $116 | $60 | $8 |
| + Debt | $13 | $2 | $0 | $0 |
| Enterprise Value | $781 | $200 | $797 | $849 |
| Revenue | $0 | $1 | $1 | $6 |
| % Growth | -100% | 30.4% | -85.1% | – |
| Gross Profit | $0 | $1 | $1 | $6 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$83 | -$49 | -$23 | -$12 |
| % Margin | – | -4,324.4% | -2,651.8% | -211.4% |
| Net Income | -$82 | -$48 | -$24 | -$13 |
| % Margin | – | -4,308.6% | -2,752.3% | -224.5% |
| EPS Diluted | -2.07 | -3.91 | -1.02 | -0.56 |
| % Growth | 47.1% | -283.3% | -82.1% | – |
| Operating Cash Flow | -$64 | -$39 | -$21 | -$16 |
| Capital Expenditures | -$2 | -$1 | -$0 | -$1 |
| Free Cash Flow | -$67 | -$40 | -$21 | -$17 |